Pfizer Inc. said a new version of its bestselling Prevnar vaccine may provide infants with better protection against common ...

Pfizer said on Wednesday its experimental pneumococcal vaccine showed significantly stronger immune response than its current shot, including up ​to 15-fold higher antibody levels against a key strain ...

Dignity Health has plans to build a 300,000-square-foot medical campus at the site of the new Arizona Cardinals performance ...

Invasive meningococcal disease caused by Neisseria meningitidis is primarily associated with serogroups A, B, C, W, X, and Y and is characterised by its sudden, unpredictable nature and devastating ...

The agency’s scientists and data contractors reviewed millions of patient records for studies that were pulled back before release. By Christina Jewett Reporting from Washington Officials at the Food ...

Vaccines are one of the most powerful tools in modern medicine. They help protect people from serious diseases by training the body’s immune system to recognize and fight infections. Over the years, ...

Lyme disease is the most common tick-borne infectious disease in the United States. There is no vaccine to protect against it in humans. Biopharmaceutical company Pfizer and Valneva, a European ...

There's actually nothing unusual going on with Pfizer's pharmaceutical business. The industry is highly competitive, capital-intensive, and driven by innovation. Unfortunately, research and ...

Outdoor enthusiasts hoping to avoid catching a potentially debilitating bacterium from a tick bite could soon have another layer of defense joining bug sprays and long clothing. New clinical trial ...

Since pharmaceutical companies Pfizer and Valneva announced positive results from their phase 3 trial of a vaccine to prevent Lyme disease last month, two questions have loomed large: Will the vaccine ...

Health Minister Greg Hunt warned the company employing the errant doctor was now ‘on notice for termination’ over the COVID ...